PEStore

Buyout PE

C9

C9 acquires controlling stakes in established, profitable businesses, from Los Angeles, California, United States. It states a focus on healthcare & life sciences and financial services.

Disclosed holdings
Earliest stated investment
HeadquartersLos Angeles, California, United States
Stated cheque sizetarget companies $5-50M revenue

Stated investment criteria

What C9 says it buys

Read from C9’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Revenue it states$5m to $50m1
Transaction typesDistressed, Recapitalisation1
OfficesLos Angeles1

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. C9 states that it takes majority or outright ownership. Nothing here is a commitment by C9 to consider any particular business, and nothing on this page is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this C9?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.